Carotid Atherosclerosis Predicts Blood Pressure Control in Patients With Hypertension: The Campania Salute Network

Costantino Mancusi1, Maria Virginia Manzi1, Giovanni de Simone1

  • 1Department of Advanced Biomedical Sciences Federico II University Naples Italy.

Insights

Carotid plaque (CP) presence in hypertensive patients predicts poorer blood pressure (BP) control over time. Early detection of CP may help identify individuals needing closer BP management for better hypertension outcomes.

Area of Science:

  • Cardiovascular Medicine
  • Hypertension Research
  • Vascular Ultrasound

Background:

  • Current hypertension guidelines do not routinely recommend carotid ultrasound for identifying organ damage.
  • Carotid plaque (CP) is linked to arterial stiffness, impacting long-term blood pressure (BP) management.
  • Investigating CP as a predictor of BP control is crucial for refining hypertension treatment strategies.

Purpose of the Study:

  • To determine if the presence of carotid plaque (CP) at baseline predicts blood pressure (BP) control during follow-up in hypertensive patients.
  • To assess the association between CP and suboptimal BP control, independent of other risk factors.

Main Methods:

  • Analysis of 6684 hypertensive patients from the Campania Salute Network (CSN) Registry with baseline carotid ultrasound.
  • Categorization of patients based on the presence or absence of carotid plaque (CP).
  • Definition of optimal BP control as average BP <140/90 mmHg (office) and <135/85 mmHg (home) during follow-up.

Main Results:

  • Patients with CP were older, more likely male, had diabetes, higher systolic BP, and more left ventricular hypertrophy.
  • Optimal office BP control was achieved by 54% of patients with CP versus 62% without (P<0.0001).
  • CP presence significantly predicted reduced probability of controlled office BP during follow-up, independent of other factors.

Conclusions:

  • Carotid plaque (CP) in treated hypertensive patients is associated with suboptimal blood pressure (BP) control.
  • This association persists independently of metabolic profile and left ventricular hypertrophy.
  • CP may serve as a valuable marker for identifying patients at risk for poor BP management.

Related Concept Videos

Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
61
Hypertension and Regulation of Blood Pressure01:18

Hypertension and Regulation of Blood Pressure

Hypertension, the most common cardiovascular disease, is diagnosed through repeated measurements of elevated blood pressure. Its risks, including damage to the kidney, heart, and brain, are directly proportional to blood pressure levels. Starting from 115/75 mm Hg, the risk of cardiovascular disease doubles with each increment of 20/10 mm Hg. The diagnosis relies on blood pressure measurements, not on patient symptoms, as hypertension is often asymptomatic until end-organ damage is imminent or...
3.3K
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
94
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
135
Hypertension III: Clinical Manifestations and Diagnostic Studies01:30

Hypertension III: Clinical Manifestations and Diagnostic Studies

Hypertension is asymptomatic and also referred to as the "silent killer" until it progresses to a severe stage or causes target organ disease. Patients may experience symptoms stemming from the strain on blood vessels and tissues in various organs or the heart's increased workload.Physical exams might show no abnormalities other than high blood pressure. Signs of vascular damage, when present, correspond to the organs supplied by the affected vessels, leading to target organ damage. For...
70
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests01:27

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
78